Anti-IgE - Omalizumab als relevante und dauerhafte Therapieoption bei schwerer Erdnussallergie

Translated title of the contribution: Anti-IgE - Omalizumab as an important and permanent therapy option for severe peanut allergy

C. Bannert, R. Gaupmann, K. Schmidthaler, M. Gona-Höpler, S. Gruber, T. Eiwegger, E. Dehlink, C. Bangert, Zsolt Szépfalusi*

*Corresponding author for this work

Research output: Journal article (peer-reviewed) › Review article

Fingerprint

Dive into the research topics of 'Anti-IgE - Omalizumab as an important and permanent therapy option for severe peanut allergy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science